

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | amino sugar catabolic process (GO:0046348) | 4.57473202 |
| 2 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.43307442 |
| 3 | * ATP hydrolysis coupled proton transport (GO:0015991) | 4.43307442 |
| 4 | * transferrin transport (GO:0033572) | 4.37028105 |
| 5 | * phagosome maturation (GO:0090382) | 4.33718052 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.30479438 |
| 7 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.23282385 |
| 8 | N-acetylneuraminate metabolic process (GO:0006054) | 4.20186603 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.05365444 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.04886841 |
| 11 | * trivalent inorganic cation transport (GO:0072512) | 4.03253346 |
| 12 | * ferric iron transport (GO:0015682) | 4.03253346 |
| 13 | presynaptic membrane assembly (GO:0097105) | 3.83960108 |
| 14 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.74555201 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.67893105 |
| 16 | presynaptic membrane organization (GO:0097090) | 3.64683627 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 3.59639304 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 3.57268492 |
| 19 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.53974718 |
| 20 | cytochrome complex assembly (GO:0017004) | 3.50776446 |
| 21 | respiratory chain complex IV assembly (GO:0008535) | 3.46817613 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.38954258 |
| 23 | proteasome assembly (GO:0043248) | 3.34893239 |
| 24 | dopamine biosynthetic process (GO:0042416) | 3.32038017 |
| 25 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.31999697 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.30133482 |
| 27 | reactive oxygen species biosynthetic process (GO:1903409) | 3.29868522 |
| 28 | ATP synthesis coupled proton transport (GO:0015986) | 3.28786891 |
| 29 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.28786891 |
| 30 | axon ensheathment in central nervous system (GO:0032291) | 3.27990068 |
| 31 | central nervous system myelination (GO:0022010) | 3.27990068 |
| 32 | protein neddylation (GO:0045116) | 3.27914953 |
| 33 | fatty acid elongation (GO:0030497) | 3.27516370 |
| 34 | respiratory electron transport chain (GO:0022904) | 3.26229641 |
| 35 | cellular extravasation (GO:0045123) | 3.25032055 |
| 36 | response to peptidoglycan (GO:0032494) | 3.21145846 |
| 37 | base-excision repair, AP site formation (GO:0006285) | 3.19790845 |
| 38 | electron transport chain (GO:0022900) | 3.19735597 |
| 39 | oligosaccharide catabolic process (GO:0009313) | 3.17676908 |
| 40 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.17584376 |
| 41 | glycosphingolipid catabolic process (GO:0046479) | 3.16118066 |
| 42 | regulation of glutamate secretion (GO:0014048) | 3.10364838 |
| 43 | neutrophil mediated immunity (GO:0002446) | 3.09600910 |
| 44 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.09284438 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.06939392 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.06756577 |
| 47 | vocalization behavior (GO:0071625) | 3.05423371 |
| 48 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.04687829 |
| 49 | glutamate secretion (GO:0014047) | 3.04386015 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.00759827 |
| 51 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.99247789 |
| 52 | positive regulation of TOR signaling (GO:0032008) | 2.98204767 |
| 53 | pH reduction (GO:0045851) | 2.97364255 |
| 54 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.95025971 |
| 55 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.93194320 |
| 56 | protein localization to synapse (GO:0035418) | 2.93159965 |
| 57 | glycolipid catabolic process (GO:0019377) | 2.93059017 |
| 58 | dopamine transport (GO:0015872) | 2.91669441 |
| 59 | negative regulation of amino acid transport (GO:0051956) | 2.91201739 |
| 60 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.91066446 |
| 61 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.89767262 |
| 62 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.89256795 |
| 63 | neuron-neuron synaptic transmission (GO:0007270) | 2.89222103 |
| 64 | protein maturation by protein folding (GO:0022417) | 2.88359449 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.88124137 |
| 66 | regulation of catecholamine metabolic process (GO:0042069) | 2.87325779 |
| 67 | regulation of dopamine metabolic process (GO:0042053) | 2.87325779 |
| 68 | DNA deamination (GO:0045006) | 2.87312807 |
| 69 | intracellular pH reduction (GO:0051452) | 2.86568284 |
| 70 | negative regulation of interleukin-12 production (GO:0032695) | 2.85864550 |
| 71 | regulation of synaptic vesicle transport (GO:1902803) | 2.85558279 |
| 72 | synaptic transmission, dopaminergic (GO:0001963) | 2.84868968 |
| 73 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.84059363 |
| 74 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.83433589 |
| 75 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.83266398 |
| 76 | NADH dehydrogenase complex assembly (GO:0010257) | 2.83266398 |
| 77 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.83266398 |
| 78 | * hydrogen ion transmembrane transport (GO:1902600) | 2.82283801 |
| 79 | regulation of mitochondrial translation (GO:0070129) | 2.80339804 |
| 80 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.79675108 |
| 81 | immunoglobulin mediated immune response (GO:0016064) | 2.79279770 |
| 82 | microglial cell activation (GO:0001774) | 2.77743578 |
| 83 | sphingolipid catabolic process (GO:0030149) | 2.75894034 |
| 84 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.75168851 |
| 85 | transmission of nerve impulse (GO:0019226) | 2.72978810 |
| 86 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.71350678 |
| 87 | * iron ion transport (GO:0006826) | 2.70325087 |
| 88 | regulation of chemokine biosynthetic process (GO:0045073) | 2.69830288 |
| 89 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.69203317 |
| 90 | ceramide catabolic process (GO:0046514) | 2.69080616 |
| 91 | membrane lipid catabolic process (GO:0046466) | 2.68027682 |
| 92 | protein deneddylation (GO:0000338) | 2.68001044 |
| 93 | glutamate receptor signaling pathway (GO:0007215) | 2.66639156 |
| 94 | synaptic transmission, glutamatergic (GO:0035249) | 2.66529912 |
| 95 | * proton transport (GO:0015992) | 2.65527061 |
| 96 | substantia nigra development (GO:0021762) | 2.65044334 |
| 97 | pyrimidine-containing compound salvage (GO:0008655) | 2.63034886 |
| 98 | pyrimidine nucleoside salvage (GO:0043097) | 2.63034886 |
| 99 | behavioral response to cocaine (GO:0048148) | 2.62594092 |
| 100 | positive regulation of prostaglandin secretion (GO:0032308) | 2.61764806 |
| 101 | * hydrogen transport (GO:0006818) | 2.61343253 |
| 102 | adult walking behavior (GO:0007628) | 2.60614365 |
| 103 | positive regulation of action potential (GO:0045760) | 2.60471630 |
| 104 | regulation of vesicle fusion (GO:0031338) | 2.59961013 |
| 105 | mating behavior (GO:0007617) | 2.59126247 |
| 106 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.58623351 |
| 107 | heme biosynthetic process (GO:0006783) | 2.57805198 |
| 108 | GDP-mannose metabolic process (GO:0019673) | 2.57792683 |
| 109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.56460477 |
| 110 | long-term synaptic potentiation (GO:0060291) | 2.55772736 |
| 111 | deoxyribonucleotide catabolic process (GO:0009264) | 2.55683706 |
| 112 | protein complex biogenesis (GO:0070271) | 2.54462937 |
| 113 | neurotransmitter secretion (GO:0007269) | 2.54203700 |
| 114 | negative regulation of growth of symbiont in host (GO:0044130) | 2.54156760 |
| 115 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.54156760 |
| 116 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.54156760 |
| 117 | regulation of growth of symbiont in host (GO:0044126) | 2.54156760 |
| 118 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.52715959 |
| 119 | startle response (GO:0001964) | 2.51727739 |
| 120 | macrophage activation (GO:0042116) | 2.51617694 |
| 121 | eosinophil chemotaxis (GO:0048245) | 2.51388972 |
| 122 | protein targeting to mitochondrion (GO:0006626) | 2.50842701 |
| 123 | postsynaptic membrane organization (GO:0001941) | 2.50696793 |
| 124 | response to cocaine (GO:0042220) | 2.48558232 |
| 125 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.48533395 |
| 126 | synaptic vesicle transport (GO:0048489) | 2.47926535 |
| 127 | establishment of synaptic vesicle localization (GO:0097480) | 2.47926535 |
| 128 | cellular response to cadmium ion (GO:0071276) | 2.47679689 |
| 129 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.47512453 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.46738271 |
| 131 | heme metabolic process (GO:0042168) | 2.46537938 |
| 132 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.45888440 |
| 133 | establishment of protein localization to mitochondrion (GO:0072655) | 2.45397577 |
| 134 | mannosylation (GO:0097502) | 2.45335015 |
| 135 | negative regulation of amine transport (GO:0051953) | 2.45252280 |
| 136 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.45004838 |
| 137 | neurotransmitter uptake (GO:0001504) | 2.44573219 |
| 138 | regulation of amino acid transport (GO:0051955) | 2.44025114 |
| 139 | macrophage activation involved in immune response (GO:0002281) | 2.43254811 |
| 140 | neuron recognition (GO:0008038) | 2.43053030 |
| 141 | neurotransmitter transport (GO:0006836) | 2.42645591 |
| 142 | C-terminal protein lipidation (GO:0006501) | 2.42404065 |
| 143 | protein localization to cilium (GO:0061512) | 2.41953271 |
| 144 | deoxyribose phosphate catabolic process (GO:0046386) | 2.39445120 |
| 145 | response to histamine (GO:0034776) | 2.38762207 |
| 146 | cellular response to zinc ion (GO:0071294) | 2.38655022 |
| 147 | positive regulation of membrane potential (GO:0045838) | 2.38399171 |
| 148 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.38336133 |
| 149 | regulation of neurotransmitter secretion (GO:0046928) | 2.37615368 |
| 150 | positive regulation of synapse assembly (GO:0051965) | 2.37271358 |
| 151 | cerebellar granule cell differentiation (GO:0021707) | 2.36234591 |
| 152 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.36228554 |
| 153 | regulation of axon regeneration (GO:0048679) | 2.35985346 |
| 154 | regulation of neuron projection regeneration (GO:0070570) | 2.35985346 |
| 155 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.35072474 |
| 156 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.35072474 |
| 157 | ATP biosynthetic process (GO:0006754) | 2.34816346 |
| 158 | granulocyte activation (GO:0036230) | 2.34639877 |
| 159 | regulation of superoxide anion generation (GO:0032928) | 2.34424339 |
| 160 | response to redox state (GO:0051775) | 2.34363268 |
| 161 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33433155 |
| 162 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33433155 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.33433155 |
| 164 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33433155 |
| 165 | modulation by symbiont of host defense response (GO:0052031) | 2.33433155 |
| 166 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33433155 |
| 167 | protein localization to mitochondrion (GO:0070585) | 2.33282045 |
| 168 | neuromuscular process controlling posture (GO:0050884) | 2.32298894 |
| 169 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.31868537 |
| 170 | synaptic vesicle maturation (GO:0016188) | 2.31516642 |
| 171 | respiratory burst (GO:0045730) | 2.30517854 |
| 172 | negative regulation of synaptic transmission (GO:0050805) | 2.30460499 |
| 173 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.29035867 |
| 174 | eosinophil migration (GO:0072677) | 2.28644882 |
| 175 | detection of calcium ion (GO:0005513) | 2.28194355 |
| 176 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.26412440 |
| 177 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.26352815 |
| 178 | gamma-aminobutyric acid transport (GO:0015812) | 2.25766452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.03398040 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.96483732 |
| 3 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.41836660 |
| 4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.14202821 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.07059622 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99756292 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.88351014 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.76835566 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73790630 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.65765660 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.54855753 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.44618168 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.37868140 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.37703878 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.34237311 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30809598 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30608055 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27186583 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20994621 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20880510 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.17277049 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16769581 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15009483 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13354435 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.13129314 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.07287755 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07242549 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.05836746 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04840099 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.03244250 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01866420 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99803199 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.95223120 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.95134713 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92820784 |
| 36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.92207677 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92152307 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.91993944 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.91993944 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90847459 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90448332 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88337487 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86316147 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.85731423 |
| 45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.82888071 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81674320 |
| 47 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.81595280 |
| 48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81514580 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.81501713 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80036745 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78856538 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.78604659 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77329728 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.76965436 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.76337651 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.73703133 |
| 57 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.71195753 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69165163 |
| 59 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.68867571 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68797656 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68465484 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67607366 |
| 63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65746649 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64446619 |
| 65 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60769396 |
| 66 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60322689 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58469131 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56316184 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54863191 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53674921 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51336365 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50321338 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49738896 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49318214 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49088822 |
| 76 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.47542917 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46509699 |
| 78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45188311 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.44961349 |
| 80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44890674 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42858817 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42655731 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41671829 |
| 84 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41228739 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40592469 |
| 86 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.40398005 |
| 87 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.39630896 |
| 88 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38527973 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37075169 |
| 90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35539067 |
| 91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35395912 |
| 92 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35340181 |
| 93 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.34295247 |
| 94 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.33696996 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33691967 |
| 96 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33416790 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31329450 |
| 98 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.31198544 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30451767 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29537111 |
| 101 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29087055 |
| 102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28852589 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27825071 |
| 104 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27812405 |
| 105 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27610603 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27073261 |
| 107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25653019 |
| 108 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24987370 |
| 109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24866924 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24451604 |
| 111 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.24345927 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.24138083 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22752894 |
| 114 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22641557 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21465850 |
| 116 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21454243 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21408443 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20388798 |
| 119 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19513249 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19100052 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18956945 |
| 122 | P68_20966046_ChIP-Seq_HELA_Human | 1.18928246 |
| 123 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18035734 |
| 124 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17894774 |
| 125 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16517241 |
| 126 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16217425 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16190225 |
| 128 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14426857 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13029019 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13029019 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12625796 |
| 132 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11632594 |
| 133 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11018021 |
| 134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.10892576 |
| 135 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09932177 |
| 136 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09910220 |
| 137 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.09559213 |
| 138 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.09491056 |
| 139 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09487829 |
| 140 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09462606 |
| 141 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09377805 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09224679 |
| 143 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09010605 |
| 144 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08224203 |
| 145 | JUN_21703547_ChIP-Seq_K562_Human | 1.07389284 |
| 146 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06251515 |
| 147 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05976626 |
| 148 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05875996 |
| 149 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05860315 |
| 150 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05795475 |
| 151 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.05425156 |
| 152 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05028077 |
| 153 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05017270 |
| 154 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04329508 |
| 155 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04138777 |
| 156 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03779493 |
| 157 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03210017 |
| 158 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.03082339 |
| 159 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02615666 |
| 160 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02573018 |
| 161 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02347497 |
| 162 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02299732 |
| 163 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02293145 |
| 164 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00788965 |
| 165 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00004573 |
| 166 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99836835 |
| 167 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99283612 |
| 168 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98636144 |
| 169 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97202367 |
| 170 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96286760 |
| 171 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95179906 |
| 172 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92155101 |
| 173 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91348116 |
| 174 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91309171 |
| 175 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91179200 |
| 176 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91079698 |
| 177 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89759565 |
| 178 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88991285 |
| 179 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88823059 |
| 180 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.88220197 |
| 181 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87746300 |
| 182 | KDM2B_26808549_Chip-Seq_REH_Human | 0.87027846 |
| 183 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84671817 |
| 184 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.84562622 |
| 185 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84294472 |
| 186 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84294472 |
| 187 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.83609101 |
| 188 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82528055 |
| 189 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82298860 |
| 190 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81187849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.89780769 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.46601729 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.16991368 |
| 4 | MP0009046_muscle_twitch | 3.04278985 |
| 5 | MP0002064_seizures | 3.02236667 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.86915608 |
| 7 | MP0004270_analgesia | 2.81204904 |
| 8 | MP0009745_abnormal_behavioral_response | 2.80155712 |
| 9 | MP0001529_abnormal_vocalization | 2.77913897 |
| 10 | MP0001905_abnormal_dopamine_level | 2.74879955 |
| 11 | MP0009840_abnormal_foam_cell | 2.59466266 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.58601456 |
| 13 | MP0002736_abnormal_nociception_after | 2.49582265 |
| 14 | MP0002272_abnormal_nervous_system | 2.44605447 |
| 15 | MP0009785_altered_susceptibility_to | 2.42955806 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.42702624 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.40486426 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.31413327 |
| 19 | MP0003436_decreased_susceptibility_to | 2.29338768 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.27385630 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.23629622 |
| 22 | MP0000920_abnormal_myelination | 2.17967802 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.16491149 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.15027859 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 2.11445513 |
| 26 | MP0005083_abnormal_biliary_tract | 2.10662652 |
| 27 | MP0001486_abnormal_startle_reflex | 2.10429788 |
| 28 | MP0005058_abnormal_lysosome_morphology | 2.04025446 |
| 29 | MP0001970_abnormal_pain_threshold | 2.03518859 |
| 30 | MP0002733_abnormal_thermal_nociception | 2.00025124 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.98027340 |
| 32 | MP0003724_increased_susceptibility_to | 1.97331089 |
| 33 | MP0003303_peritoneal_inflammation | 1.94309493 |
| 34 | MP0003329_amyloid_beta_deposits | 1.90413961 |
| 35 | MP0004142_abnormal_muscle_tone | 1.89962522 |
| 36 | MP0005025_abnormal_response_to | 1.89761847 |
| 37 | MP0002822_catalepsy | 1.89234326 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.88029205 |
| 39 | MP0000343_altered_response_to | 1.86410215 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.85004458 |
| 41 | MP0005365_abnormal_bile_salt | 1.83291569 |
| 42 | MP0005671_abnormal_response_to | 1.79732197 |
| 43 | MP0005171_absent_coat_pigmentation | 1.73577595 |
| 44 | MP0003690_abnormal_glial_cell | 1.66938766 |
| 45 | MP0004742_abnormal_vestibular_system | 1.65570494 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.64063433 |
| 47 | MP0005387_immune_system_phenotype | 1.63349221 |
| 48 | MP0001790_abnormal_immune_system | 1.63349221 |
| 49 | MP0004924_abnormal_behavior | 1.61626186 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.61626186 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.59157509 |
| 52 | MP0003186_abnormal_redox_activity | 1.58032814 |
| 53 | MP0006035_abnormal_mitochondrial_morpho | 1.56332858 |
| 54 | MP0003634_abnormal_glial_cell | 1.54295426 |
| 55 | MP0008260_abnormal_autophagy | 1.53327287 |
| 56 | MP0009764_decreased_sensitivity_to | 1.52122868 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.51461983 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.51164225 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.49731272 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.48454096 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.48421173 |
| 62 | MP0002229_neurodegeneration | 1.46011259 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.45616898 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.45445518 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.45377380 |
| 66 | MP0000604_amyloidosis | 1.43951001 |
| 67 | MP0005451_abnormal_body_composition | 1.43484133 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.41754158 |
| 69 | MP0001984_abnormal_olfaction | 1.41515432 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.40157833 |
| 71 | MP0002723_abnormal_immune_serum | 1.39427636 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.39077408 |
| 73 | MP0008469_abnormal_protein_level | 1.36057276 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.35733111 |
| 75 | MP0002420_abnormal_adaptive_immunity | 1.35426314 |
| 76 | MP0001819_abnormal_immune_cell | 1.33684812 |
| 77 | MP0003195_calcinosis | 1.33100788 |
| 78 | MP0000778_abnormal_nervous_system | 1.31864688 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.29437886 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.28597130 |
| 81 | MP0001502_abnormal_circadian_rhythm | 1.28154616 |
| 82 | MP0001853_heart_inflammation | 1.26941320 |
| 83 | MP0006082_CNS_inflammation | 1.26417927 |
| 84 | MP0005464_abnormal_platelet_physiology | 1.24603087 |
| 85 | MP0003122_maternal_imprinting | 1.24217648 |
| 86 | MP0002557_abnormal_social/conspecific_i | 1.22110656 |
| 87 | MP0003011_delayed_dark_adaptation | 1.20084959 |
| 88 | MP0004858_abnormal_nervous_system | 1.19846228 |
| 89 | MP0002693_abnormal_pancreas_physiology | 1.19672388 |
| 90 | MP0004043_abnormal_pH_regulation | 1.19509577 |
| 91 | MP0003786_premature_aging | 1.18655879 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 1.17874866 |
| 93 | MP0002184_abnormal_innervation | 1.17343554 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 1.16579690 |
| 95 | MP0002882_abnormal_neuron_morphology | 1.15999854 |
| 96 | MP0001800_abnormal_humoral_immune | 1.15514561 |
| 97 | MP0005310_abnormal_salivary_gland | 1.15097557 |
| 98 | MP0004885_abnormal_endolymph | 1.14649867 |
| 99 | MP0003633_abnormal_nervous_system | 1.11785082 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 1.11347431 |
| 101 | MP0002132_abnormal_respiratory_system | 1.11319424 |
| 102 | MP0001188_hyperpigmentation | 1.11304073 |
| 103 | MP0001533_abnormal_skeleton_physiology | 1.11169348 |
| 104 | MP0000685_abnormal_immune_system | 1.11145806 |
| 105 | MP0000955_abnormal_spinal_cord | 1.10964028 |
| 106 | MP0008569_lethality_at_weaning | 1.10653074 |
| 107 | MP0003879_abnormal_hair_cell | 1.10500742 |
| 108 | MP0005535_abnormal_body_temperature | 1.10156704 |
| 109 | MP0003631_nervous_system_phenotype | 1.09654023 |
| 110 | MP0008058_abnormal_DNA_repair | 1.07159688 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 1.06975440 |
| 112 | MP0002638_abnormal_pupillary_reflex | 1.06803736 |
| 113 | MP0001764_abnormal_homeostasis | 1.06231307 |
| 114 | MP0003632_abnormal_nervous_system | 1.06180865 |
| 115 | MP0002090_abnormal_vision | 1.05919386 |
| 116 | MP0002148_abnormal_hypersensitivity_rea | 1.05366399 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 1.04018926 |
| 118 | MP0001963_abnormal_hearing_physiology | 1.02366376 |
| 119 | MP0005332_abnormal_amino_acid | 1.01949514 |
| 120 | MP0004811_abnormal_neuron_physiology | 1.01375400 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 1.00740131 |
| 122 | MP0000013_abnormal_adipose_tissue | 1.00313265 |
| 123 | MP0005166_decreased_susceptibility_to | 0.97991273 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96442343 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.94238272 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 0.94075826 |
| 127 | MP0005379_endocrine/exocrine_gland_phen | 0.93851679 |
| 128 | MP0000358_abnormal_cell_content/ | 0.91684820 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.89345561 |
| 130 | MP0005409_darkened_coat_color | 0.88696582 |
| 131 | MP0004510_myositis | 0.87783807 |
| 132 | MP0001756_abnormal_urination | 0.86938420 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.86350521 |
| 134 | MP0005084_abnormal_gallbladder_morpholo | 0.86313567 |
| 135 | MP0003136_yellow_coat_color | 0.85097917 |
| 136 | MP0000716_abnormal_immune_system | 0.84259802 |
| 137 | MP0003123_paternal_imprinting | 0.83392693 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.83004954 |
| 139 | MP0001664_abnormal_digestion | 0.82984338 |
| 140 | MP0009643_abnormal_urine_homeostasis | 0.82338815 |
| 141 | MP0001485_abnormal_pinna_reflex | 0.80678384 |
| 142 | MP0002405_respiratory_system_inflammati | 0.79716888 |
| 143 | MP0002069_abnormal_eating/drinking_beha | 0.76137128 |
| 144 | MP0003075_altered_response_to | 0.76081685 |
| 145 | MP0010329_abnormal_lipoprotein_level | 0.75511947 |
| 146 | MP0008873_increased_physiological_sensi | 0.75054677 |
| 147 | MP0000372_irregular_coat_pigmentation | 0.73553366 |
| 148 | MP0002419_abnormal_innate_immunity | 0.73376465 |
| 149 | MP0005410_abnormal_fertilization | 0.71281528 |
| 150 | MP0005253_abnormal_eye_physiology | 0.70705585 |
| 151 | MP0002752_abnormal_somatic_nervous | 0.70216605 |
| 152 | MP0008872_abnormal_physiological_respon | 0.66632329 |
| 153 | MP0008874_decreased_physiological_sensi | 0.66160979 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.65550993 |
| 155 | MP0000681_abnormal_thyroid_gland | 0.65239916 |
| 156 | MP0002163_abnormal_gland_morphology | 0.64093811 |
| 157 | MP0001727_abnormal_embryo_implantation | 0.63278076 |
| 158 | MP0003787_abnormal_imprinting | 0.62996371 |
| 159 | MP0005164_abnormal_response_to | 0.62931884 |
| 160 | MP0005000_abnormal_immune_tolerance | 0.62516428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.75517717 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.25837025 |
| 3 | Atonic seizures (HP:0010819) | 3.98264281 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.79365291 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.73381532 |
| 6 | Myokymia (HP:0002411) | 3.62324725 |
| 7 | Pheochromocytoma (HP:0002666) | 3.62301311 |
| 8 | Neurofibrillary tangles (HP:0002185) | 3.58838892 |
| 9 | Progressive macrocephaly (HP:0004481) | 3.57050388 |
| 10 | Neuroendocrine neoplasm (HP:0100634) | 3.47188622 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.42535105 |
| 12 | Loss of speech (HP:0002371) | 3.40356256 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.28557005 |
| 14 | Limb dystonia (HP:0002451) | 3.24945069 |
| 15 | Acute encephalopathy (HP:0006846) | 3.24306463 |
| 16 | Focal seizures (HP:0007359) | 3.18690055 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.16467906 |
| 18 | Visual hallucinations (HP:0002367) | 3.16075567 |
| 19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.12134277 |
| 20 | Hepatocellular necrosis (HP:0001404) | 3.11326366 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.09095151 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.09095151 |
| 23 | Hypothermia (HP:0002045) | 3.00945575 |
| 24 | Absence seizures (HP:0002121) | 2.99690325 |
| 25 | Dialeptic seizures (HP:0011146) | 2.97244312 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 2.96264658 |
| 27 | Increased CSF lactate (HP:0002490) | 2.95117136 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.88453373 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.88453373 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 2.88453373 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86009476 |
| 32 | Increased muscle lipid content (HP:0009058) | 2.84811688 |
| 33 | Polyphagia (HP:0002591) | 2.79269786 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.75251579 |
| 35 | Akinesia (HP:0002304) | 2.74068746 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.72462679 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.72388945 |
| 38 | Obstructive lung disease (HP:0006536) | 2.69018210 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69018210 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 2.68738533 |
| 41 | Sensory axonal neuropathy (HP:0003390) | 2.68263464 |
| 42 | Renal Fanconi syndrome (HP:0001994) | 2.67935584 |
| 43 | Petechiae (HP:0000967) | 2.67304714 |
| 44 | Abnormal hair whorl (HP:0010721) | 2.65374487 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.63284269 |
| 46 | Febrile seizures (HP:0002373) | 2.61627734 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 2.60874128 |
| 48 | Leukodystrophy (HP:0002415) | 2.58600503 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57966129 |
| 50 | Parakeratosis (HP:0001036) | 2.57134873 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.55886506 |
| 52 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.55654911 |
| 53 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.55654911 |
| 54 | Gait imbalance (HP:0002141) | 2.55125419 |
| 55 | Hyperventilation (HP:0002883) | 2.51602216 |
| 56 | Abnormality of glycolysis (HP:0004366) | 2.50836811 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.50836811 |
| 58 | Increased hepatocellular lipid droplets (HP:0006565) | 2.50360796 |
| 59 | Stomatitis (HP:0010280) | 2.48889425 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.43775577 |
| 61 | Optic disc pallor (HP:0000543) | 2.41393758 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.40498416 |
| 63 | Exertional dyspnea (HP:0002875) | 2.37157776 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36913223 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36913223 |
| 66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36913223 |
| 67 | Congenital primary aphakia (HP:0007707) | 2.36554197 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.35411004 |
| 69 | Failure to thrive in infancy (HP:0001531) | 2.31435279 |
| 70 | Hepatic necrosis (HP:0002605) | 2.30661382 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.30402343 |
| 72 | Vaginal atresia (HP:0000148) | 2.30166614 |
| 73 | Cerebral hemorrhage (HP:0001342) | 2.29395680 |
| 74 | Dysostosis multiplex (HP:0000943) | 2.27300037 |
| 75 | Increased serum lactate (HP:0002151) | 2.26683521 |
| 76 | Nephrogenic diabetes insipidus (HP:0009806) | 2.26603830 |
| 77 | Mutism (HP:0002300) | 2.26353796 |
| 78 | Genital tract atresia (HP:0001827) | 2.25961310 |
| 79 | Progressive inability to walk (HP:0002505) | 2.25675826 |
| 80 | Abnormal eating behavior (HP:0100738) | 2.24922126 |
| 81 | Respiratory failure (HP:0002878) | 2.24760277 |
| 82 | Prolonged neonatal jaundice (HP:0006579) | 2.22542256 |
| 83 | Respiratory difficulties (HP:0002880) | 2.21497549 |
| 84 | Progressive microcephaly (HP:0000253) | 2.21482566 |
| 85 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.20863000 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.19960993 |
| 87 | Diminished movement (HP:0002374) | 2.19351942 |
| 88 | Recurrent bacterial skin infections (HP:0005406) | 2.17547850 |
| 89 | Dysmetria (HP:0001310) | 2.16870888 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15754030 |
| 91 | Mediastinal lymphadenopathy (HP:0100721) | 2.10360680 |
| 92 | CNS demyelination (HP:0007305) | 2.10202963 |
| 93 | Myoclonus (HP:0001336) | 2.07962683 |
| 94 | Emotional lability (HP:0000712) | 2.05493447 |
| 95 | Anxiety (HP:0000739) | 2.04322198 |
| 96 | Mucopolysacchariduria (HP:0008155) | 2.04110357 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04110357 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.02116499 |
| 99 | Broad-based gait (HP:0002136) | 2.02063922 |
| 100 | Neuronal loss in central nervous system (HP:0002529) | 2.01522630 |
| 101 | Lipid accumulation in hepatocytes (HP:0006561) | 2.01018965 |
| 102 | Abnormality of the corticospinal tract (HP:0002492) | 2.00359148 |
| 103 | Hypokinesia (HP:0002375) | 2.00047269 |
| 104 | Retinal dysplasia (HP:0007973) | 1.99384443 |
| 105 | Delusions (HP:0000746) | 1.98995445 |
| 106 | Disinhibition (HP:0000734) | 1.98310977 |
| 107 | Episodic fever (HP:0001954) | 1.98184953 |
| 108 | Poor suck (HP:0002033) | 1.97362170 |
| 109 | Nausea (HP:0002018) | 1.93642732 |
| 110 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.93320924 |
| 111 | Diplopia (HP:0000651) | 1.93029727 |
| 112 | Abnormality of binocular vision (HP:0011514) | 1.93029727 |
| 113 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.92990640 |
| 114 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.92961856 |
| 115 | Generalized myoclonic seizures (HP:0002123) | 1.92385162 |
| 116 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91798274 |
| 117 | Psychosis (HP:0000709) | 1.90911611 |
| 118 | Myositis (HP:0100614) | 1.90900217 |
| 119 | Abnormality of renal resorption (HP:0011038) | 1.90792397 |
| 120 | Glycosuria (HP:0003076) | 1.89947199 |
| 121 | Abnormality of urine glucose concentration (HP:0011016) | 1.89947199 |
| 122 | Microvesicular hepatic steatosis (HP:0001414) | 1.89492604 |
| 123 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88989999 |
| 124 | Dicarboxylic aciduria (HP:0003215) | 1.88989999 |
| 125 | Ketoacidosis (HP:0001993) | 1.88017951 |
| 126 | Esotropia (HP:0000565) | 1.87779374 |
| 127 | Gaze-evoked nystagmus (HP:0000640) | 1.87432115 |
| 128 | Spastic gait (HP:0002064) | 1.87195499 |
| 129 | Retinal atrophy (HP:0001105) | 1.86523104 |
| 130 | Agitation (HP:0000713) | 1.86126526 |
| 131 | Recurrent skin infections (HP:0001581) | 1.86117827 |
| 132 | Increased serum ferritin (HP:0003281) | 1.85079808 |
| 133 | J-shaped sella turcica (HP:0002680) | 1.83116217 |
| 134 | Methylmalonic aciduria (HP:0012120) | 1.82934387 |
| 135 | Cerebral edema (HP:0002181) | 1.82848581 |
| 136 | Epileptiform EEG discharges (HP:0011182) | 1.82236769 |
| 137 | Cerebral hypomyelination (HP:0006808) | 1.80938010 |
| 138 | Testicular atrophy (HP:0000029) | 1.80365137 |
| 139 | Axonal loss (HP:0003447) | 1.80308866 |
| 140 | Ankle clonus (HP:0011448) | 1.80067225 |
| 141 | Fetal akinesia sequence (HP:0001989) | 1.77738095 |
| 142 | Abnormality of the anterior horn cell (HP:0006802) | 1.77634501 |
| 143 | Degeneration of anterior horn cells (HP:0002398) | 1.77634501 |
| 144 | Progressive neurologic deterioration (HP:0002344) | 1.77540699 |
| 145 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.77298849 |
| 146 | Peripheral hypomyelination (HP:0007182) | 1.77266520 |
| 147 | Abnormal gallbladder physiology (HP:0012438) | 1.77213664 |
| 148 | Cholecystitis (HP:0001082) | 1.77213664 |
| 149 | Gliosis (HP:0002171) | 1.76825985 |
| 150 | Exercise intolerance (HP:0003546) | 1.75743163 |
| 151 | Oligomenorrhea (HP:0000876) | 1.74540507 |
| 152 | Microretrognathia (HP:0000308) | 1.74289810 |
| 153 | Lactic acidosis (HP:0003128) | 1.73765182 |
| 154 | Lethargy (HP:0001254) | 1.73433721 |
| 155 | Ragged-red muscle fibers (HP:0003200) | 1.71702930 |
| 156 | Diminished motivation (HP:0000745) | 1.70567858 |
| 157 | Urticaria (HP:0001025) | 1.69187320 |
| 158 | Type I transferrin isoform profile (HP:0003642) | 1.68612178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.04753206 |
| 2 | NME2 | 3.75773007 |
| 3 | TESK2 | 3.33419142 |
| 4 | MAP3K12 | 3.24901452 |
| 5 | ARAF | 3.16784720 |
| 6 | VRK2 | 2.88118896 |
| 7 | OXSR1 | 2.83799386 |
| 8 | RIPK4 | 2.82968014 |
| 9 | TESK1 | 2.69171894 |
| 10 | MAP3K11 | 2.52422563 |
| 11 | STK39 | 2.49901010 |
| 12 | BCKDK | 2.47005595 |
| 13 | NTRK3 | 2.37836238 |
| 14 | EPHA4 | 2.32686870 |
| 15 | ERN1 | 2.27600889 |
| 16 | CDK19 | 2.18442821 |
| 17 | CCNB1 | 2.15233282 |
| 18 | MAP2K7 | 2.08860283 |
| 19 | PBK | 1.98506093 |
| 20 | GRK5 | 1.97242713 |
| 21 | PDK2 | 1.84347473 |
| 22 | PLK2 | 1.83957984 |
| 23 | TNIK | 1.80953620 |
| 24 | PRPF4B | 1.78792975 |
| 25 | MAP3K4 | 1.72901568 |
| 26 | TAOK1 | 1.63808336 |
| 27 | BCR | 1.63338565 |
| 28 | TYK2 | 1.62578575 |
| 29 | BMPR2 | 1.60677463 |
| 30 | MAP3K9 | 1.57947523 |
| 31 | DAPK2 | 1.56572619 |
| 32 | GRK7 | 1.53915419 |
| 33 | MAP4K2 | 1.52375540 |
| 34 | PNCK | 1.51356911 |
| 35 | NTRK1 | 1.50180044 |
| 36 | NME1 | 1.49016285 |
| 37 | WNK4 | 1.48634742 |
| 38 | FGR | 1.41065029 |
| 39 | MAPKAPK5 | 1.39136919 |
| 40 | MARK1 | 1.38772813 |
| 41 | TBK1 | 1.38629380 |
| 42 | MAP3K3 | 1.34701594 |
| 43 | CAMK2B | 1.33532537 |
| 44 | BRAF | 1.31015781 |
| 45 | TNK2 | 1.29969428 |
| 46 | ADRBK2 | 1.26670201 |
| 47 | MINK1 | 1.26501455 |
| 48 | MAP4K1 | 1.25913239 |
| 49 | TLK1 | 1.21941815 |
| 50 | BMPR1B | 1.16942767 |
| 51 | CSNK1G3 | 1.15311164 |
| 52 | MAP2K6 | 1.12670102 |
| 53 | IKBKB | 1.11948915 |
| 54 | CDK5 | 1.11895406 |
| 55 | CAMK2A | 1.10430985 |
| 56 | TXK | 1.08593942 |
| 57 | TAOK2 | 1.08099825 |
| 58 | CAMK2D | 1.08045969 |
| 59 | STK16 | 1.07842304 |
| 60 | MAP2K3 | 1.07760649 |
| 61 | PKN1 | 1.07576885 |
| 62 | DAPK1 | 1.07530920 |
| 63 | CAMKK2 | 1.07427633 |
| 64 | FES | 1.06775722 |
| 65 | CAMK1D | 1.03828995 |
| 66 | PRKCE | 1.03031979 |
| 67 | CSNK1G2 | 1.02729602 |
| 68 | LIMK1 | 0.99108893 |
| 69 | MST4 | 0.98291673 |
| 70 | UHMK1 | 0.97632790 |
| 71 | SIK3 | 0.96844102 |
| 72 | MAPK13 | 0.96406349 |
| 73 | TRIM28 | 0.96308460 |
| 74 | MAP3K13 | 0.95956983 |
| 75 | CSK | 0.95728685 |
| 76 | PRKCG | 0.94249223 |
| 77 | MAP2K4 | 0.92597817 |
| 78 | SGK494 | 0.88889477 |
| 79 | SGK223 | 0.88889477 |
| 80 | MAP3K5 | 0.88112034 |
| 81 | CAMK2G | 0.86498791 |
| 82 | PINK1 | 0.86026737 |
| 83 | PAK6 | 0.84768967 |
| 84 | CDK14 | 0.83480522 |
| 85 | NTRK2 | 0.81418611 |
| 86 | KSR2 | 0.79424480 |
| 87 | KDR | 0.78955188 |
| 88 | PIM2 | 0.77888400 |
| 89 | CDK18 | 0.77300245 |
| 90 | PTK2B | 0.77217756 |
| 91 | MATK | 0.77210452 |
| 92 | IKBKE | 0.76567015 |
| 93 | ZAP70 | 0.74723913 |
| 94 | NEK6 | 0.73856470 |
| 95 | GRK1 | 0.73788449 |
| 96 | GRK6 | 0.73142172 |
| 97 | LRRK2 | 0.73047283 |
| 98 | BUB1 | 0.72724471 |
| 99 | TAOK3 | 0.72458309 |
| 100 | CDK15 | 0.71801185 |
| 101 | MYLK | 0.70637265 |
| 102 | DAPK3 | 0.70180942 |
| 103 | PRKCI | 0.69865497 |
| 104 | LYN | 0.68901775 |
| 105 | AKT3 | 0.66517338 |
| 106 | ADRBK1 | 0.66372157 |
| 107 | TSSK6 | 0.66155979 |
| 108 | MAP3K14 | 0.66007420 |
| 109 | ROCK2 | 0.65039030 |
| 110 | IRAK4 | 0.64832452 |
| 111 | EPHB1 | 0.63787210 |
| 112 | ABL2 | 0.61508544 |
| 113 | CDK11A | 0.61328653 |
| 114 | MUSK | 0.60306085 |
| 115 | VRK1 | 0.59622900 |
| 116 | CSNK1G1 | 0.57094118 |
| 117 | PDPK1 | 0.56556430 |
| 118 | BLK | 0.56167361 |
| 119 | PHKG2 | 0.55003980 |
| 120 | PHKG1 | 0.55003980 |
| 121 | MAP3K2 | 0.53788204 |
| 122 | MET | 0.53325374 |
| 123 | IRAK3 | 0.50770848 |
| 124 | ZAK | 0.49915542 |
| 125 | WNK1 | 0.49132452 |
| 126 | SYK | 0.48705819 |
| 127 | CSNK1A1L | 0.48231612 |
| 128 | RPS6KA5 | 0.47865292 |
| 129 | WNK3 | 0.47570462 |
| 130 | ERBB4 | 0.47286805 |
| 131 | PAK4 | 0.46364895 |
| 132 | MOS | 0.45954342 |
| 133 | PAK1 | 0.45208552 |
| 134 | PRKG2 | 0.44888032 |
| 135 | DYRK2 | 0.44675642 |
| 136 | DYRK1A | 0.44398221 |
| 137 | CHUK | 0.43941275 |
| 138 | YES1 | 0.43786745 |
| 139 | FYN | 0.43282133 |
| 140 | MAP3K1 | 0.42639593 |
| 141 | MAPK15 | 0.41848137 |
| 142 | PRKACA | 0.41599097 |
| 143 | CAMKK1 | 0.40835666 |
| 144 | PRKCQ | 0.39342352 |
| 145 | MST1R | 0.36275428 |
| 146 | EIF2AK1 | 0.35792240 |
| 147 | PRKCD | 0.35566580 |
| 148 | CSNK1A1 | 0.34572991 |
| 149 | IRAK2 | 0.33804455 |
| 150 | LCK | 0.32437442 |
| 151 | CAMK1 | 0.30222343 |
| 152 | PDK1 | 0.29226352 |
| 153 | HCK | 0.27864243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.44576301 |
| 2 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.07511146 |
| 3 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.58720655 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.00137405 |
| 5 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.82033067 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.63251310 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.53867440 |
| 8 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.33965055 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93655032 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.89472746 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 1.89279894 |
| 12 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.89023479 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.87945111 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.78733815 |
| 15 | * Phagosome_Homo sapiens_hsa04145 | 1.77423419 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.71774656 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68204226 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63851277 |
| 19 | * Lysosome_Homo sapiens_hsa04142 | 1.61261784 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.60701228 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.51530959 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47487644 |
| 23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46619757 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46179018 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.44871571 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43093015 |
| 27 | Proteasome_Homo sapiens_hsa03050 | 1.42586206 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39981286 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.39467297 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38824699 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.35210661 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32043068 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30304603 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29615733 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28670090 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28390720 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 1.25843461 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.24472894 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23585978 |
| 40 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21525096 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19839612 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.17187973 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15261790 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.12849841 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12560025 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12538751 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12510488 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 1.12134650 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10519030 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10441622 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.09862943 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08800164 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06610820 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 1.05408044 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00961925 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99233805 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97506448 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96843909 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92153966 |
| 60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.89378824 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88444769 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87791224 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.87056430 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82627407 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81745316 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80882650 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79929452 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.78370541 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77820889 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77154563 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76180371 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74857297 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74473963 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.74452812 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70884510 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70433534 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70328225 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.68442486 |
| 79 | * Tuberculosis_Homo sapiens_hsa05152 | 0.64658927 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.63799905 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62187611 |
| 82 | Ribosome_Homo sapiens_hsa03010 | 0.62048583 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60017623 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.59240669 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.57225646 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57055568 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.56800038 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.56489062 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56397442 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55541172 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55313519 |
| 92 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53968070 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53258537 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.52133050 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51864315 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.51647222 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47249137 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45480836 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44754178 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44093684 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41345486 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.40967763 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.40922713 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40190304 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40167230 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40036402 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39027468 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38173360 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38128935 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.38114884 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37671800 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.36898954 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35662060 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35509358 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35134105 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34543186 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34357448 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34136223 |
| 119 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34123629 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.34063351 |
| 121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33552881 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33366721 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33285362 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32398265 |
| 125 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32264979 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31425876 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30962042 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30352686 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29505070 |
| 130 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28813795 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28502878 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28106258 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.27925417 |
| 134 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.26713262 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26331523 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25890034 |
| 137 | Alcoholism_Homo sapiens_hsa05034 | 0.25868725 |
| 138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25860144 |
| 139 | Legionellosis_Homo sapiens_hsa05134 | 0.25065588 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25008025 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24719446 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.24548643 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.22641912 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21464202 |
| 145 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.20595061 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19581747 |
| 147 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19324942 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.17667478 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.17249727 |
| 150 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.17098793 |

